Tornier N.V. (TRNX) 20.92 $TRNX
Board Elections, Dividend Authorizations, Leadership Appointments, and Earnings Results - Analyst Notes on CareFusion, Teleflex, Haemonetics, ICU and Tornier
PR Newswire - Mon May 12, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CareFusion Corporation (NYSE: CFN), Teleflex Incorporated (NYSE: TFX), Haemonetics Corp. (NYSE: HAE), ICU Medical, Inc. (NASDAQ: ICUI) and Tornier N.V. (NASDAQ: TRNX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2294-100free.
Tornier to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
GlobeNewswire - Thu May 08, 8:31AM CDT
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference.
Could A War In Ukraine Ever Actually Happen? 5 European Stocks To Watch
at The Street - Tue May 06, 4:19PM CDT
James Dennin, Kapitall: Ukraine concerns are keeping prices of European stocks very low, with volume 18% below its average for the [...]
Tornier Reports First Quarter 2014 Results
GlobeNewswire - Tue May 06, 3:23PM CDT
-- Revenue increased 6.8% over prior year quarter, in constant currency
Tornier Announces First Quarter 2014 Conference Call
GlobeNewswire - Wed Apr 16, 3:16PM CDT
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 30, 2014 after the close of the regular trading market on Tuesday, May 6, 2014.
Hedge Funds Like European Shipping Stocks As Market Recovers
at The Street - Wed Mar 26, 8:00AM CDT
James Dennin, Kapitall: As European markets recover, hedge funds are buying lots of shares of shipping stocks. European stocks have been in [...]
Tornier Announces Secondary Offering of Ordinary Shares
GlobeNewswire - Mon Feb 24, 3:07PM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the commencement of a proposed underwritten public offering of 5,125,000 ordinary shares by TMG Holdings Cooperatief U.A., an affiliate of Warburg Pincus LLC. Tornier will not sell any ordinary shares in this offering or receive any proceeds from this offering.
Xylem to participate in the Stifel Nicolaus Weisel 2014 Industrials Conference
Business Wire - Fri Feb 21, 11:43AM CST
Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world's most challenging water issues, announced today that its Vice President and Director of Investor Relations Phil De Sousa will participate in the Stifel Nicolaus Weisel 2014 Industrials Conference at the Palace Hotel in New York City on Thursday, February 27, 2014.
Anthelio(R) Healthcare Solutions Acquired Industry Leading Application - ENGAGE - from The Garage
Business Wire - Fri Feb 21, 11:37AM CST
Anthelio Healthcare Solutions, the largest independent provider of technology and services to hospitals, physicians practice groups and other healthcare providers, announced it is launching ENGAGE, a next generation mobile application for patient engagement that they have acquired from The Garage, a leading health innovation start-up company. ENGAGE informs, educates, entertains and connects patients with their health care providers and enriches their experience. ENGAGE also gives providers and payers flexibility to have dynamic content available for patients through easy to use web-based content management software. ENGAGE is currently published on the Apple App store as an iPad application.
Tornier Reports Fourth Quarter and Fiscal Year 2013 Results and Provides 2014 Outlook
GlobeNewswire - Thu Feb 20, 3:20PM CST
-- Phase 1 of U.S. distribution channel transition complete; Phase 2 underway, with focus on sales force optimization and training
Tornier to Present at the 2014 RBC Capital Markets Global Healthcare Conference
GlobeNewswire - Mon Feb 10, 6:30AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the 2014 RBC Capital Markets Global Healthcare Conference.
Tornier Announces Fourth Quarter and Full Year 2013 Conference Call
GlobeNewswire - Tue Feb 04, 9:48PM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 29, 2013 after the close of the regular trading market on Thursday, February 20, 2014.
Henkel Announces Reformulated, Sustainable LOCTITE® Dri-Loc® Pre-applied Threadlockers and Pre-applied Anti-seize
PR Newswire - Thu Jan 23, 8:47AM CST
With its commitment to smart chemistry solutions, Henkel has reformulated its LOCTITE® Dri-Loc® pre-applied threadlockers and pre-applied anti-seize with a sustainable biocide and removed formaldehyde. These adhesives are designed for excellent resistance to vibration loosening on any threaded fastener, such as nuts in various automotive applications, including chassis, powertrain and interiors. A complete range of products for specific customer applications is available with various strengths, temperature resistance and lubricating properties. With these innovative OEM-approved solutions, there is no need to apply adhesives, sealants or any other locking or sealing device during assembly.
Tornier Announces Preliminary Fourth Quarter and Full Year 2013 Revenue
GlobeNewswire - Mon Jan 13, 6:30AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today preliminary fourth quarter and full year 2013 revenue results. The Company expects revenue for the fourth quarter of 2013 to be in the range of $83 to $84 million, representing growth compared to the year-ago quarter of between 5.1% and 6.3% as reported and 3.8% to 5.1% in constant currency. For the full year 2013, the Company expects revenue to be in the range of $310.5 to $311.5 million, representing growth of between 11.9% and 12.3 % as reported and 11.1% to 11.5% in constant currency. Giving pro-forma effect to Tornier's fourth quarter 2012 acquisition of OrthoHelix Surgical Designs, Inc., to include OrthoHelix revenue for the full year 2012, full year 2013 constant currency revenue growth is expected to be between 3.3% and 3.7%.
Tornier to Present at 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 30, 8:00AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference.
Tornier to Present at Piper Jaffray 25th Annual Healthcare Conference
GlobeNewswire - Wed Nov 20, 8:00AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Piper Jaffray 25th Annual Healthcare Conference.
Certifications, Presentation of Study Results and Earnings Releases - Research Report on Agilent, Mindray, Bard, Tornier, and Life Technologies
PR Newswire - Mon Nov 11, 7:08AM CST
Editor Note: For more information about this release, please scroll to bottom.
Nasdaq stocks posting largest volume increases
AP - Wed Aug 07, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Wed Aug 07, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Tornier NV Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 07, 12:33PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Tornier N.V. , a medical device company...
Board Elections, Dividend Authorizations, Leadership Appointments, and Earnings Results - Analyst Notes on CareFusion, Teleflex, Haemonetics, ICU and Tornier
PR Newswire - Mon May 12, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CareFusion Corporation (NYSE: CFN), Teleflex Incorporated (NYSE: TFX), Haemonetics Corp. (NYSE: HAE), ICU Medical, Inc. (NASDAQ: ICUI) and Tornier N.V. (NASDAQ: TRNX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2294-100free.
Tornier to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
GlobeNewswire - Thu May 08, 8:31AM CDT
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference.
Could A War In Ukraine Ever Actually Happen? 5 European Stocks To Watch
at The Street - Tue May 06, 4:19PM CDT
James Dennin, Kapitall: Ukraine concerns are keeping prices of European stocks very low, with volume 18% below its average for the [...]
Tornier Reports First Quarter 2014 Results
GlobeNewswire - Tue May 06, 3:23PM CDT
-- Revenue increased 6.8% over prior year quarter, in constant currency
Tornier Announces First Quarter 2014 Conference Call
GlobeNewswire - Wed Apr 16, 3:16PM CDT
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 30, 2014 after the close of the regular trading market on Tuesday, May 6, 2014.
Hedge Funds Like European Shipping Stocks As Market Recovers
at The Street - Wed Mar 26, 8:00AM CDT
James Dennin, Kapitall: As European markets recover, hedge funds are buying lots of shares of shipping stocks. European stocks have been in [...]
Tornier Announces Secondary Offering of Ordinary Shares
GlobeNewswire - Mon Feb 24, 3:07PM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the commencement of a proposed underwritten public offering of 5,125,000 ordinary shares by TMG Holdings Cooperatief U.A., an affiliate of Warburg Pincus LLC. Tornier will not sell any ordinary shares in this offering or receive any proceeds from this offering.
Xylem to participate in the Stifel Nicolaus Weisel 2014 Industrials Conference
Business Wire - Fri Feb 21, 11:43AM CST
Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world's most challenging water issues, announced today that its Vice President and Director of Investor Relations Phil De Sousa will participate in the Stifel Nicolaus Weisel 2014 Industrials Conference at the Palace Hotel in New York City on Thursday, February 27, 2014.
Anthelio(R) Healthcare Solutions Acquired Industry Leading Application - ENGAGE - from The Garage
Business Wire - Fri Feb 21, 11:37AM CST
Anthelio Healthcare Solutions, the largest independent provider of technology and services to hospitals, physicians practice groups and other healthcare providers, announced it is launching ENGAGE, a next generation mobile application for patient engagement that they have acquired from The Garage, a leading health innovation start-up company. ENGAGE informs, educates, entertains and connects patients with their health care providers and enriches their experience. ENGAGE also gives providers and payers flexibility to have dynamic content available for patients through easy to use web-based content management software. ENGAGE is currently published on the Apple App store as an iPad application.
Tornier Reports Fourth Quarter and Fiscal Year 2013 Results and Provides 2014 Outlook
GlobeNewswire - Thu Feb 20, 3:20PM CST
-- Phase 1 of U.S. distribution channel transition complete; Phase 2 underway, with focus on sales force optimization and training
Tornier to Present at the 2014 RBC Capital Markets Global Healthcare Conference
GlobeNewswire - Mon Feb 10, 6:30AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the 2014 RBC Capital Markets Global Healthcare Conference.
Tornier Announces Fourth Quarter and Full Year 2013 Conference Call
GlobeNewswire - Tue Feb 04, 9:48PM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 29, 2013 after the close of the regular trading market on Thursday, February 20, 2014.
Henkel Announces Reformulated, Sustainable LOCTITE® Dri-Loc® Pre-applied Threadlockers and Pre-applied Anti-seize
PR Newswire - Thu Jan 23, 8:47AM CST
With its commitment to smart chemistry solutions, Henkel has reformulated its LOCTITE® Dri-Loc® pre-applied threadlockers and pre-applied anti-seize with a sustainable biocide and removed formaldehyde. These adhesives are designed for excellent resistance to vibration loosening on any threaded fastener, such as nuts in various automotive applications, including chassis, powertrain and interiors. A complete range of products for specific customer applications is available with various strengths, temperature resistance and lubricating properties. With these innovative OEM-approved solutions, there is no need to apply adhesives, sealants or any other locking or sealing device during assembly.
Tornier Announces Preliminary Fourth Quarter and Full Year 2013 Revenue
GlobeNewswire - Mon Jan 13, 6:30AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today preliminary fourth quarter and full year 2013 revenue results. The Company expects revenue for the fourth quarter of 2013 to be in the range of $83 to $84 million, representing growth compared to the year-ago quarter of between 5.1% and 6.3% as reported and 3.8% to 5.1% in constant currency. For the full year 2013, the Company expects revenue to be in the range of $310.5 to $311.5 million, representing growth of between 11.9% and 12.3 % as reported and 11.1% to 11.5% in constant currency. Giving pro-forma effect to Tornier's fourth quarter 2012 acquisition of OrthoHelix Surgical Designs, Inc., to include OrthoHelix revenue for the full year 2012, full year 2013 constant currency revenue growth is expected to be between 3.3% and 3.7%.
Tornier to Present at 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 30, 8:00AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference.
Tornier to Present at Piper Jaffray 25th Annual Healthcare Conference
GlobeNewswire - Wed Nov 20, 8:00AM CST
Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company's President and Chief Executive Officer, and Shawn McCormick, the Company's Chief Financial Officer, will present at the Piper Jaffray 25th Annual Healthcare Conference.
Certifications, Presentation of Study Results and Earnings Releases - Research Report on Agilent, Mindray, Bard, Tornier, and Life Technologies
PR Newswire - Mon Nov 11, 7:08AM CST
Editor Note: For more information about this release, please scroll to bottom.
Nasdaq stocks posting largest volume increases
AP - Wed Aug 07, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Wed Aug 07, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Tornier NV Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 07, 12:33PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Tornier N.V. , a medical device company...
